RU2395281C2 - Фармацевтическая композиция для лечения диспластических процессов шейки матки - Google Patents

Фармацевтическая композиция для лечения диспластических процессов шейки матки Download PDF

Info

Publication number
RU2395281C2
RU2395281C2 RU2008135764/15A RU2008135764A RU2395281C2 RU 2395281 C2 RU2395281 C2 RU 2395281C2 RU 2008135764/15 A RU2008135764/15 A RU 2008135764/15A RU 2008135764 A RU2008135764 A RU 2008135764A RU 2395281 C2 RU2395281 C2 RU 2395281C2
Authority
RU
Russia
Prior art keywords
epigallocatechin
gallate
treatment
dna
cervix
Prior art date
Application number
RU2008135764/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2008135764A (ru
Inventor
Всеволод Иванович Киселев (RU)
Всеволод Иванович Киселев
Original Assignee
Всеволод Иванович Киселев
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всеволод Иванович Киселев filed Critical Всеволод Иванович Киселев
Priority to RU2008135764/15A priority Critical patent/RU2395281C2/ru
Priority to EA201100417A priority patent/EA018383B1/ru
Priority to PCT/RU2009/000412 priority patent/WO2010027294A1/ru
Priority to UAA201011132A priority patent/UA95583C2/uk
Publication of RU2008135764A publication Critical patent/RU2008135764A/ru
Application granted granted Critical
Publication of RU2395281C2 publication Critical patent/RU2395281C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2008135764/15A 2008-09-04 2008-09-04 Фармацевтическая композиция для лечения диспластических процессов шейки матки RU2395281C2 (ru)

Priority Applications (4)

Application Number Priority Date Filing Date Title
RU2008135764/15A RU2395281C2 (ru) 2008-09-04 2008-09-04 Фармацевтическая композиция для лечения диспластических процессов шейки матки
EA201100417A EA018383B1 (ru) 2008-09-04 2009-08-18 Композиция для лечения диспластических процессов шейки матки
PCT/RU2009/000412 WO2010027294A1 (ru) 2008-09-04 2009-08-18 Композиция для лечения диспластических процессов шейки матки
UAA201011132A UA95583C2 (uk) 2008-09-04 2009-08-18 Композиція для лікування диспластичних процесів шийки матки

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008135764/15A RU2395281C2 (ru) 2008-09-04 2008-09-04 Фармацевтическая композиция для лечения диспластических процессов шейки матки

Publications (2)

Publication Number Publication Date
RU2008135764A RU2008135764A (ru) 2010-03-10
RU2395281C2 true RU2395281C2 (ru) 2010-07-27

Family

ID=41797309

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008135764/15A RU2395281C2 (ru) 2008-09-04 2008-09-04 Фармацевтическая композиция для лечения диспластических процессов шейки матки

Country Status (4)

Country Link
EA (1) EA018383B1 (uk)
RU (1) RU2395281C2 (uk)
UA (1) UA95583C2 (uk)
WO (1) WO2010027294A1 (uk)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2454232C2 (ru) * 2010-09-16 2012-06-27 Федеральное государственное бюджетное учреждение "Российский онкологический научный центр имени Н.Н. Блохина" Российской академии медицинских наук (ФГБУ "РОНЦ им. Н.Н. Блохина" РАМН) Применение производных трииндолилметана в качестве противоопухолевых средств
RU2601621C2 (ru) * 2015-03-18 2016-11-10 Общество с ограниченной ответственностью "Фармацевтический завод иммунных лекарственных средств" Натрия дезоксирибонуклеата суппозитории, ректальные и вагинальные

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2456987C1 (ru) * 2011-03-21 2012-07-27 Сергей Владимирович Енгашев Способ получения желатиновых капсул на основе 3,31- дииндолилметана
GB2533381A (en) * 2014-12-18 2016-06-22 Nordic Labs Ltd Novel treatment of STIs
GB2542106A (en) * 2015-04-01 2017-03-15 Nordic Labs Ltd Novel treatment of STIs
RU2601893C1 (ru) * 2015-11-30 2016-11-10 Всеволод Иванович Киселев Лекарственное средство на основе индол-3-карбинола с повышенной эпигенетической активностью
GB2565492A (en) * 2016-05-16 2019-02-13 Nordic Labs Ltd Means for treating sexually-transmitted infectious diseases
CN108969602A (zh) * 2018-09-29 2018-12-11 南京依美生物科技有限公司 一种治疗人乳头状瘤病毒阳转阴的中药组合物及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
RU2196568C1 (ru) * 2001-08-08 2003-01-20 Киселев Всеволод Иванович Фармацевтическая композиция для профилактики и лечения дисплазий и рака шейки матки и папилломатоза гортани, а также способ профилактики и лечения этих заболеваний на ее основе
RU2301666C2 (ru) * 2002-01-11 2007-06-27 Маттиас Рат Обладающий питательными свойствами фармацевтический состав на основе полифенолов и его использование при лечении рака
RU2318510C1 (ru) * 2006-04-19 2008-03-10 Всеволод Иванович Киселев Суппозитории вагинальные на основе 3,3`-дииндолилметана (метиндола)
RU2315594C1 (ru) * 2006-09-01 2008-01-27 Всеволод Иванович Киселев Антиэстрогенное и антипролиферативное средство для лечения и профилактики заболеваний женской репродуктивной системы

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2454232C2 (ru) * 2010-09-16 2012-06-27 Федеральное государственное бюджетное учреждение "Российский онкологический научный центр имени Н.Н. Блохина" Российской академии медицинских наук (ФГБУ "РОНЦ им. Н.Н. Блохина" РАМН) Применение производных трииндолилметана в качестве противоопухолевых средств
RU2601621C2 (ru) * 2015-03-18 2016-11-10 Общество с ограниченной ответственностью "Фармацевтический завод иммунных лекарственных средств" Натрия дезоксирибонуклеата суппозитории, ректальные и вагинальные

Also Published As

Publication number Publication date
WO2010027294A1 (ru) 2010-03-11
EA201100417A1 (ru) 2011-10-31
EA018383B1 (ru) 2013-07-30
UA95583C2 (uk) 2011-08-10
RU2008135764A (ru) 2010-03-10

Similar Documents

Publication Publication Date Title
RU2395281C2 (ru) Фармацевтическая композиция для лечения диспластических процессов шейки матки
Yanofsky et al. Genital warts: a comprehensive review
Riva et al. Extended carbon dioxide laser vaporization in the treatment of subclinical papillomavirus infection of the lower genital tract
WO2002085327A2 (en) Use of nsaids for prevention and treatment of cellular abnormalities of the female reproductive tract
Lai et al. Medical and surgical approaches to vulvar intraepithelial neoplasia
JP2011509956A (ja) イミダゾリキノリン誘導体を用いた大腸疾病の治療又は結腸直腸癌腫の予防
CN103588660A (zh) 一种新型的酰基苯胺化合物及用途
RU2318510C1 (ru) Суппозитории вагинальные на основе 3,3`-дииндолилметана (метиндола)
CN104353058A (zh) 商陆抗病毒蛋白冻干粉复合剂及其制备方法
Tang et al. Therapeutic effects of topical photodynamic therapy with 5-aminolevulinic acid on cervical high-grade squamous intraepithelial lesions
Wang et al. The effect of local photodynamic therapy with 5-aminolevulinic acid in treating different grades of cervical intraepithelial neoplasia
Kimberlin et al. Juvenile onset recurrent respiratory papillomatosis: possibilities for successful antiviral therapy
Khamjan et al. Natural and synthetic drugs and formulations for intravaginal HPV clearance
Panzer et al. The antimitotic effects of Ukrain™, a Chelidonium majus alkaloid derivative, are reversible in vitro
D’Costa et al. Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression
RU2552332C1 (ru) Способ лечения плоскоклеточных интраэпителиальных поражений шейки матки
RU2701525C1 (ru) Способ комбинированной терапии дисплазии шейки матки, ассоциированной с вирусами папилломы человека
Yorganci et al. A case report of multicentric verrucous carcinoma of the female genital tract
JP2017070310A (ja) 上皮細胞におけるヒトパピローマウイルスゲノムの特異的なメチル化に関連する化合物および方法
US20090247641A1 (en) Hydrazone agents to treat cutaneous lesions
Kirby et al. Genital human papillomavirus infections
US20140341940A1 (en) Immunomodulator for the treatment of cancerous tumors in the epithelial tissue lining surfaces inside or outside body organs
Chituku et al. The Development of Locoregional Therapies as a Strategy for Reducing Cervical Cancer Mortality in Low to Middle Income Countries.
DeRossi et al. The management of oral human papillomavirus with topical cidofovir: a case report
JP2011502474A5 (uk)

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20180907